Livzon Pharma Announces RMB 12.39 Cash Dividend per 10 Shares for Q3 2026, Payment Slated for 23 December 2026

Bulletin Express
10/23

Livzon Pharmaceutical Group Inc. (Livzon Pharma) has declared an ordinary third-quarter cash dividend of RMB 12.39 per 10 shares for the reporting period ended 30 September 2026.

Shareholder approval is scheduled for 12 November 2026. The shares will trade ex-dividend on 25 November 2026, with the record date set for 26 November 2026. Share transfers must be lodged with Tricor Investor Services Limited by 16:30 on 26 November 2026.

Dividend cheques will be dispatched on or before 23 December 2026. Industrial and Commercial Bank of China (Asia) Limited will act as the Hong Kong paying agent. The payment currency for H-shareholders and the applicable exchange rate will be announced closer to the distribution date.

Withholding tax will be applied at 10% for non-resident enterprise shareholders and 20% for resident individual shareholders registered within the PRC.

The company’s board consists of Executive Directors Liu Daping (Chairman and President) and Tang Yanggang (Vice Chairman); Non-Executive Directors Lin Nanqi and Qiu Qingfeng; Employee Representative Director Ran Yongmei; and Independent Non-Executive Directors Luo Huiyuan, Cui Lijie, Wang Zhiyao and Kang Li.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10